Condition
Endometrium Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Endometrium Cancer clinical trials that are recruiting, at sites in 6 countries (most in China (2), Italy (2), United States (2)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest Endometrium Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| National registry of endometrial cancer cases in Italy | — | Roma | Recruiting | Apr 30, 2026 |
| IDE034 for adults with advanced solid tumors that express B7-H3 and PTK7 | Phase 1 | Duarte, California and 25 other locations | Recruiting | Mar 31, 2026 |
| Diet approaches to help overweight women with endometrial cancer preserve fertility and lose weight | — | Beijing | Recruiting | Jan 6, 2026 |
| Using AI to predict risks in endometrial cancer management | — | Rome | Recruiting | Feb 24, 2025 |
| Weight management for overweight endometrial cancer patients undergoing fertility-sparing treatment | — | Beijing, China | Recruiting | Dec 13, 2023 |
| Testing VLS-1488 for advanced cancers | Phase 1/2 | Los Angeles, California and 13 other locations | Recruiting | Jun 15, 2023 |
| Pembrolizumab plus Ataluren for metastatic colorectal or endometrial cancer with mismatch repair changes | Phase 1/2 | Amsterdam, North Holland | Recruiting | Jul 10, 2019 |
All recruiting trials (7)
-
National registry of endometrial cancer cases in Italy
This project will collect clinical and molecular information from adults treated for endometrial cancer at participating Italian oncology centers to see if a national database can improve understanding of outcomes and care.
-
IDE034 for adults with advanced solid tumors that express B7-H3 and PTK7
This trial will test IDE034 to see if it is safe and works in adults with advanced or metastatic solid tumors that express B7-H3 and PTK7.
-
Diet approaches to help overweight women with endometrial cancer preserve fertility and lose weight
This study will see if intermittent fasting or a low-energy balanced diet help overweight or obese women with endometrial cancer lose weight and improve metabolic and tumor-related outcomes while they undergo fertility-preserving treatment.
-
Using AI to predict risks in endometrial cancer management
This study is testing if using artificial intelligence can help doctors better predict risks and improve treatment for women with endometrial cancer, especially to help preserve fertility in those with low-risk profiles.
-
Weight management for overweight endometrial cancer patients undergoing fertility-sparing treatment
This study tests if a weight management program can help overweight women with endometrial cancer who want to preserve their fertility feel better and improve their treatment results.
-
Testing VLS-1488 for advanced cancers
This study is testing a new oral medication called VLS-1488 to see if it is safe and effective for people with advanced solid tumors.
-
Pembrolizumab plus Ataluren for metastatic colorectal or endometrial cancer with mismatch repair changes
This trial will try the combination of pembrolizumab and ataluren in adults with metastatic colorectal cancer (with or without mismatch repair deficiency) or metastatic mismatch-repair-deficient endometrial cancer to see if the treatment is safe and helps shrink tumors.
Related topics
Quick answers
How many Endometrium Cancer clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (2 trials), Italy (2 trials), United States (2 trials), Netherlands (1 trial), Georgia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.